TMCnet News
RAPT Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare ConferenceSOUTH SAN FRANCISCO, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases, today announced that Brian Wong, M.D., Ph.D., its President and CEO, will present a corporate update and company overview at the 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16th at 11:30 a.m. Pacific Time in San Francisco. A live webcast and audio archive of the presentation may be accessed on the RAPT Therapeutics website at https://investors.rapt.comevents-and-presentations. Please connect to the website 10 minutes prior to the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. About RAPT Therapeutics, Inc. Media Contact: Investor Contact:
|